Loading…

Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature

Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently publishe...

Full description

Saved in:
Bibliographic Details
Published in:Acta histochemica 2019-08, Vol.121 (6), p.765-767
Main Authors: Ricci, Costantino, Dika, Emi, Di Nanni, Doriana Donatella, Zannetti, Guido, Lambertini, Martina, Corti, Barbara
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923
cites cdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923
container_end_page 767
container_issue 6
container_start_page 765
container_title Acta histochemica
container_volume 121
creator Ricci, Costantino
Dika, Emi
Di Nanni, Doriana Donatella
Zannetti, Guido
Lambertini, Martina
Corti, Barbara
description Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.
doi_str_mv 10.1016/j.acthis.2019.06.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2246242349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0065128119300947</els_id><sourcerecordid>2246242349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</originalsourceid><addsrcrecordid>eNp9UcuO1DAQjBCIHRb-AKE-cklo23nMXECj0fKQFnGBs9VxOoyHJJ61nUX7c3wbzmbZI6dWuavcXV1Z9lpgIVDU704FmXi0oZAodgXWBaJ8km1ELbY5qkY-zTaIdZULuRUX2YsQToi4QyWfZxdKSIUNVpvsz8HNQwdXX_dAUwfmLrpf7CnaCRpoGebA_TxAgp0N6fXnbMMxFYjemqMbeBxpAEPe2MmNBL13I5iByeeGhwHCzUyjmwPco0feB9gnEBgCe8thlbnZQ8dn8nHkKd7vQ9Cmfg-eby3_BtdDPDIMNi47zp5fZs96GgK_eqiX2Y-PV98Pn_Prb5--HPbXuVG1jDm3omJMZ1OmKuueVCtMXTeNIqxIKdwJllvGVkrTERvVSUNIZJYO8U6qy-zt-u_Zu5uZQ9SjDYslmji501KWtSylKneJWq5U410Innt99nYkf6cF6iU5fdJrcnpJTmOtU3JJ9uZhwtyO3D2K_kWVCO9XAief6RpeB2N5MtxZzybqztn_T_gLfHOveA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2246242349</pqid></control><display><type>article</type><title>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</title><source>ScienceDirect Journals</source><creator>Ricci, Costantino ; Dika, Emi ; Di Nanni, Doriana Donatella ; Zannetti, Guido ; Lambertini, Martina ; Corti, Barbara</creator><creatorcontrib>Ricci, Costantino ; Dika, Emi ; Di Nanni, Doriana Donatella ; Zannetti, Guido ; Lambertini, Martina ; Corti, Barbara</creatorcontrib><description>Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.</description><identifier>ISSN: 0065-1281</identifier><identifier>EISSN: 1618-0372</identifier><identifier>DOI: 10.1016/j.acthis.2019.06.002</identifier><identifier>PMID: 31230705</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell - classification ; Carcinoma, Squamous Cell - diagnosis ; Carcinoma, Squamous Cell - metabolism ; Carcinoma, Squamous Cell - pathology ; Clear-cell squamous cell carcinoma ; Diagnosis, Differential ; E2F6 Transcription Factor - metabolism ; Female ; Humans ; Immunohistochemistry ; Keratin-7 - metabolism ; Male ; Neoplasm Proteins - metabolism ; Skin Neoplasms - classification ; Skin Neoplasms - diagnosis ; Skin Neoplasms - metabolism ; Skin Neoplasms - pathology ; Tricholemmal carcinoma</subject><ispartof>Acta histochemica, 2019-08, Vol.121 (6), p.765-767</ispartof><rights>2019 Elsevier GmbH</rights><rights>Copyright © 2019 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</citedby><cites>FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31230705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ricci, Costantino</creatorcontrib><creatorcontrib>Dika, Emi</creatorcontrib><creatorcontrib>Di Nanni, Doriana Donatella</creatorcontrib><creatorcontrib>Zannetti, Guido</creatorcontrib><creatorcontrib>Lambertini, Martina</creatorcontrib><creatorcontrib>Corti, Barbara</creatorcontrib><title>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</title><title>Acta histochemica</title><addtitle>Acta Histochem</addtitle><description>Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Squamous Cell - classification</subject><subject>Carcinoma, Squamous Cell - diagnosis</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Clear-cell squamous cell carcinoma</subject><subject>Diagnosis, Differential</subject><subject>E2F6 Transcription Factor - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Keratin-7 - metabolism</subject><subject>Male</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Skin Neoplasms - classification</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - metabolism</subject><subject>Skin Neoplasms - pathology</subject><subject>Tricholemmal carcinoma</subject><issn>0065-1281</issn><issn>1618-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9UcuO1DAQjBCIHRb-AKE-cklo23nMXECj0fKQFnGBs9VxOoyHJJ61nUX7c3wbzmbZI6dWuavcXV1Z9lpgIVDU704FmXi0oZAodgXWBaJ8km1ELbY5qkY-zTaIdZULuRUX2YsQToi4QyWfZxdKSIUNVpvsz8HNQwdXX_dAUwfmLrpf7CnaCRpoGebA_TxAgp0N6fXnbMMxFYjemqMbeBxpAEPe2MmNBL13I5iByeeGhwHCzUyjmwPco0feB9gnEBgCe8thlbnZQ8dn8nHkKd7vQ9Cmfg-eby3_BtdDPDIMNi47zp5fZs96GgK_eqiX2Y-PV98Pn_Prb5--HPbXuVG1jDm3omJMZ1OmKuueVCtMXTeNIqxIKdwJllvGVkrTERvVSUNIZJYO8U6qy-zt-u_Zu5uZQ9SjDYslmji501KWtSylKneJWq5U410Innt99nYkf6cF6iU5fdJrcnpJTmOtU3JJ9uZhwtyO3D2K_kWVCO9XAief6RpeB2N5MtxZzybqztn_T_gLfHOveA</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Ricci, Costantino</creator><creator>Dika, Emi</creator><creator>Di Nanni, Doriana Donatella</creator><creator>Zannetti, Guido</creator><creator>Lambertini, Martina</creator><creator>Corti, Barbara</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190801</creationdate><title>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</title><author>Ricci, Costantino ; Dika, Emi ; Di Nanni, Doriana Donatella ; Zannetti, Guido ; Lambertini, Martina ; Corti, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Squamous Cell - classification</topic><topic>Carcinoma, Squamous Cell - diagnosis</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Clear-cell squamous cell carcinoma</topic><topic>Diagnosis, Differential</topic><topic>E2F6 Transcription Factor - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Keratin-7 - metabolism</topic><topic>Male</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Skin Neoplasms - classification</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - metabolism</topic><topic>Skin Neoplasms - pathology</topic><topic>Tricholemmal carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ricci, Costantino</creatorcontrib><creatorcontrib>Dika, Emi</creatorcontrib><creatorcontrib>Di Nanni, Doriana Donatella</creatorcontrib><creatorcontrib>Zannetti, Guido</creatorcontrib><creatorcontrib>Lambertini, Martina</creatorcontrib><creatorcontrib>Corti, Barbara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta histochemica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ricci, Costantino</au><au>Dika, Emi</au><au>Di Nanni, Doriana Donatella</au><au>Zannetti, Guido</au><au>Lambertini, Martina</au><au>Corti, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature</atitle><jtitle>Acta histochemica</jtitle><addtitle>Acta Histochem</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>121</volume><issue>6</issue><spage>765</spage><epage>767</epage><pages>765-767</pages><issn>0065-1281</issn><eissn>1618-0372</eissn><abstract>Tricholemmal carcinoma is a malignant cutaneous adnexal tumor showing outer root sheath differentiation, thought to be the malignant counterpart of trichilemmoma. Although the real existence of tricholemmal carcinoma continues to be a matter of debate, it has been introduced in the recently published 4th edition of World Health Organization classification of skin tumors. Herein, we evaluated whether immunohistochemistry (EMA, CK7, CK5/14, p63, p16, and Ber-EP4) supports tricholemmal carcinoma as a separate entity and whether it could be useful in this differential diagnosis. A total of 9 cases, 3 tricholemmal carcinomas and 6 clear-cell squamous cell carcinomas were evaluated on the basis of histological criteria suggested by the WHO. In our opinion, although these results need to be validated in larger series, they support tricholemmal carcinoma as a separate entity and suggest an immunohistochemical profile (clear-cell squamous cell carcinomas: EMA diffusely positive, CK7 negative; tricholemmal carcinoma: EMA negative, CK7 patchy or moderately positive) that could be useful for this differential diagnosis.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>31230705</pmid><doi>10.1016/j.acthis.2019.06.002</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0065-1281
ispartof Acta histochemica, 2019-08, Vol.121 (6), p.765-767
issn 0065-1281
1618-0372
language eng
recordid cdi_proquest_miscellaneous_2246242349
source ScienceDirect Journals
subjects Aged
Aged, 80 and over
Carcinoma, Squamous Cell - classification
Carcinoma, Squamous Cell - diagnosis
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - pathology
Clear-cell squamous cell carcinoma
Diagnosis, Differential
E2F6 Transcription Factor - metabolism
Female
Humans
Immunohistochemistry
Keratin-7 - metabolism
Male
Neoplasm Proteins - metabolism
Skin Neoplasms - classification
Skin Neoplasms - diagnosis
Skin Neoplasms - metabolism
Skin Neoplasms - pathology
Tricholemmal carcinoma
title Could EMA and cytokeratin 7 be useful in distinguishing tricholemmal carcinoma from clear-cell squamous cell carcinoma? A case series from our department and a brief review of the literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T19%3A51%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Could%20EMA%20and%20cytokeratin%207%20be%20useful%20in%20distinguishing%20tricholemmal%20carcinoma%20from%20clear-cell%20squamous%20cell%20carcinoma?%20A%20case%20series%20from%20our%20department%20and%20a%20brief%20review%20of%20the%20literature&rft.jtitle=Acta%20histochemica&rft.au=Ricci,%20Costantino&rft.date=2019-08-01&rft.volume=121&rft.issue=6&rft.spage=765&rft.epage=767&rft.pages=765-767&rft.issn=0065-1281&rft.eissn=1618-0372&rft_id=info:doi/10.1016/j.acthis.2019.06.002&rft_dat=%3Cproquest_cross%3E2246242349%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-eb15e01013c546fa3b1c66773a05a33091e28e0b22cdaec3d2ca0aac3091ae923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2246242349&rft_id=info:pmid/31230705&rfr_iscdi=true